These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 19297194)

  • 1. FluBlok, a next generation influenza vaccine manufactured in insect cells.
    Cox MM; Hollister JR
    Biologicals; 2009 Jun; 37(3):182-9. PubMed ID: 19297194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months.
    King JC; Cox MM; Reisinger K; Hedrick J; Graham I; Patriarca P
    Vaccine; 2009 Nov; 27(47):6589-94. PubMed ID: 19716456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fast track influenza virus vaccine produced in insect cells.
    Cox MM; Hashimoto Y
    J Invertebr Pathol; 2011 Jul; 107 Suppl():S31-41. PubMed ID: 21784229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of a novel influenza vaccine using insect cells: protection against drifted strains.
    Cox MM; Karl Anderson D
    Influenza Other Respir Viruses; 2007 Jan; 1(1):35-40. PubMed ID: 19453478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technology transfer and scale-up of the Flublok recombinant hemagglutinin (HA) influenza vaccine manufacturing process.
    Buckland B; Boulanger R; Fino M; Srivastava I; Holtz K; Khramtsov N; McPherson C; Meghrous J; Kubera P; Cox MM
    Vaccine; 2014 Sep; 32(42):5496-502. PubMed ID: 25131727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel recombinant influenza vaccine in insect cells.
    McPherson CE
    Biologicals; 2008 Nov; 36(6):350-3. PubMed ID: 18804387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FluBlok, a recombinant hemagglutinin influenza vaccine.
    Cox MM; Patriarca PA; Treanor J
    Influenza Other Respir Viruses; 2008 Nov; 2(6):211-9. PubMed ID: 19453397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress on baculovirus-derived influenza vaccines.
    Cox MM
    Curr Opin Mol Ther; 2008 Feb; 10(1):56-61. PubMed ID: 18228182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, efficacy, and immunogenicity of Flublok in the prevention of seasonal influenza in adults.
    Cox MM; Izikson R; Post P; Dunkle L
    Ther Adv Vaccines; 2015 Jul; 3(4):97-108. PubMed ID: 26478817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baculovirus-expressed influenza vaccine. A novel technology for safe and expeditious vaccine production for human use.
    Safdar A; Cox MM
    Expert Opin Investig Drugs; 2007 Jul; 16(7):927-34. PubMed ID: 17594180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissolved carbon dioxide determines the productivity of a recombinant hemagglutinin component of an influenza vaccine produced by insect cells.
    Meghrous J; Khramtsov N; Buckland BC; Cox MM; Palomares LA; Srivastava IK
    Biotechnol Bioeng; 2015 Nov; 112(11):2267-75. PubMed ID: 25943562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using plant cells as influenza vaccine substrates.
    Chichester JA; Haaheim LR; Yusibov V
    Expert Rev Vaccines; 2009 Apr; 8(4):493-8. PubMed ID: 19348564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza virus-like particle vaccines.
    Haynes JR
    Expert Rev Vaccines; 2009 Apr; 8(4):435-45. PubMed ID: 19348559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baculovirus vector as a delivery vehicle for influenza vaccines.
    He F; Madhan S; Kwang J
    Expert Rev Vaccines; 2009 Apr; 8(4):455-67. PubMed ID: 19348561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mammalian cell-culture technique for consistent production of a well-tolerated and immunogenic trivalent subunit influenza vaccine.
    Ambrozaitis A; Groth N; Bugarini R; Sparacio V; Podda A; Lattanzi M
    Vaccine; 2009 Oct; 27(43):6022-9. PubMed ID: 19666152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical data on Fluarix: an inactivated split seasonal influenza vaccine.
    El Sahly HM; Keitel WA
    Expert Rev Vaccines; 2008 Aug; 7(6):713-9. PubMed ID: 18665769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of a novel influenza vaccine derived from a continuous cell line].
    Kistner O; Barrett N; Mundt W; Reiter M; Schober-Bendixen S; Eder G; Dorner F
    ALTEX; 2001; 18(1):50-4. PubMed ID: 11248852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trivalent MDCK cell culture-derived influenza vaccine Optaflu (Novartis Vaccines).
    Doroshenko A; Halperin SA
    Expert Rev Vaccines; 2009 Jun; 8(6):679-88. PubMed ID: 19485748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant trivalent influenza vaccine (flublok(®)): a review of its use in the prevention of seasonal influenza in adults.
    Yang LP
    Drugs; 2013 Aug; 73(12):1357-66. PubMed ID: 23928902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration.
    Künzi V; Klap JM; Seiberling MK; Herzog C; Hartmann K; Kürsteiner O; Kompier R; Grimaldi R; Goudsmit J
    Vaccine; 2009 Jun; 27(27):3561-7. PubMed ID: 19464535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.